{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:56:45Z","timestamp":1792036605446,"version":"4.4.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.thromres.2006.07.005","type":"journal-article","created":{"date-parts":[[2006,9,9]],"date-time":"2006-09-09T11:17:15Z","timestamp":1157800635000},"page":"105-116","source":"Crossref","is-referenced-by-count":48,"title":["Freeze-dried whole plasma: Evaluating sucrose, trehalose, sorbitol, mannitol and glycine as stabilizers"],"prefix":"10.1016","volume":"120","author":[{"given":"Irina","family":"Bakaltcheva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Marie","family":"O'Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Hmel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Ogbu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2006.07.005_bib1","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1423-0410.1992.tb05097.x","article-title":"Manufacture and in vitro characterization of a solvent\/detergent-treated human plasma","volume":"63","author":"Hellstern","year":"1992","journal-title":"Vox Sang"},{"key":"10.1016\/j.thromres.2006.07.005_bib2","first-page":"92","article-title":"Results of a quality-control study of lyophilized pooled plasmas which have been virally inactivated using a solvent detergent method (modified Horowitz procedure)","volume":"28","author":"Trobisch","year":"1991","journal-title":"Beitr Infusionsther"},{"key":"10.1016\/j.thromres.2006.07.005_bib3","first-page":"157","article-title":"Quality control of three different conventional fresh-frozen plasma preparations and one new virus-inactivated lyophilized pooled plasma preparation","volume":"69","author":"Hugler","year":"1991","journal-title":"Klin Wochenschr"},{"key":"10.1016\/j.thromres.2006.07.005_bib4","first-page":"169","article-title":"Response of hemophilia with bleeding to fresh dry plasma","volume":"24","author":"Krutvacho","year":"1993","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"10.1016\/j.thromres.2006.07.005_bib5","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1365-2516.2004.00928.x","article-title":"Survival analysis of patients with haemophilia at the International Haemophilia Training Centre, Bangkok, Thailand","volume":"10","author":"Chuansumrit","year":"2004","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2006.07.005_bib6","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1537-2995.1968.tb02395.x","article-title":"Statement on normal (whole, pooled) human plasma","volume":"8","year":"1968","journal-title":"Transfusion"},{"key":"10.1016\/j.thromres.2006.07.005_bib7","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1182\/blood.V79.3.826.826","article-title":"Solvent\/detergent-treated plasma: a virus-inactivated substitute for fresh frozen plasma","volume":"79","author":"Horowitz","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2006.07.005_bib8","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1423-0410.2000.tb00065.x","article-title":"The use of riboflavin for the inactivation of pathogens in blood products","volume":"78","author":"Goodrich","year":"2000","journal-title":"Vox Sang"},{"key":"10.1016\/j.thromres.2006.07.005_bib9","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S0037-1963(01)90118-0","article-title":"Fundamentals of the psoralen-based Helinx technology for inactivation of infectious pathogens and leukocytes in platelets and plasma","volume":"38","author":"Wollowitz","year":"2001","journal-title":"Semin Hematol"},{"key":"10.1016\/j.thromres.2006.07.005_bib10","series-title":"Lyophilization of Biopharmaceuticals. Part 2","first-page":"139","article-title":"Excipients for use in lyophilized pharmaceutical peptide, protein, and other bioproducts","author":"Costantino","year":"2004"},{"key":"10.1016\/j.thromres.2006.07.005_bib11","first-page":"18","article-title":"The formulation of recombinant factor IX: stability, robustness, convenience","volume":"35","author":"Bush","year":"1998","journal-title":"Semin Hematol"},{"key":"10.1016\/j.thromres.2006.07.005_bib12","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1023\/A:1012199816852","article-title":"Development of freeze-dried albumin-free formulation of recombinant factor VIII SQ","volume":"14","author":"Osterberg","year":"1997","journal-title":"Pharm Res"},{"key":"10.1016\/j.thromres.2006.07.005_bib13","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0037-1963(01)90107-6","article-title":"B-domain deleted recombinant factor VIII formulation and stability","volume":"38","author":"Osterberg","year":"2001","journal-title":"Semin Hematol"},{"key":"10.1016\/j.thromres.2006.07.005_bib14","unstructured":"Besman M, Bjornson E, Jameel F, Kashi R, Pikal M, Tchessalov S, Carpenter J. Albumin-free factor VIII formulations US Patent 6,586,573."},{"key":"10.1016\/j.thromres.2006.07.005_bib15","unstructured":"MacPhee M, Drohan W, Beal D, Friedman S, Tuthill D, Bayer V. Hemostatic sandwich bandage. US Patent 6,762,336."},{"key":"10.1016\/j.thromres.2006.07.005_bib16","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1046\/j.1537-2995.1997.37397240208.x","article-title":"The effect of hypothonicity, glutamine, and glycine on red cell preservation","volume":"37","author":"Greenwalt","year":"1997","journal-title":"Transfusion"},{"key":"10.1016\/j.thromres.2006.07.005_bib17","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1046\/j.1537-2995.1999.39090991.x","article-title":"The viability of autologous human red cells stored in additive solution 5 and exposed to 25degrees C for 24hours","volume":"39","author":"Reid","year":"1999","journal-title":"Transfusion"},{"key":"10.1016\/j.thromres.2006.07.005_bib18","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.0042-9007.2003.00366.x","article-title":"Modified formulation of CPDA for storage of whole blood, and of SAGM for storage of red blood cells, to maintain the concentration of 2,3-diphosphoglycerate","volume":"85","author":"Kurup","year":"2003","journal-title":"Vox Sang"},{"key":"10.1016\/j.thromres.2006.07.005_bib19","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0049-3848(02)00335-3","article-title":"Hypertonic resuscitation and blood coagulation. In vitro comparison of several hypertonic solutions for their action on platelets and plasma coagulation","volume":"107","author":"Wilder","year":"2002","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2006.07.005_bib20","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1006\/cryo.2001.2353","article-title":"The trehalose myth revisited: Introduction to a symposium on stabilization of cells in the dry state","volume":"43","author":"Crowe","year":"2001","journal-title":"Cryobiology"},{"key":"10.1016\/j.thromres.2006.07.005_bib21","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1023\/A:1005605616356","article-title":"Stabilization of immunoconjugates by trehalose","volume":"22","author":"Esteves","year":"2000","journal-title":"Biotechnol Lett"},{"key":"10.1016\/j.thromres.2006.07.005_bib22","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0049-3848(02)00057-9","article-title":"Influence of freeze-drying on the clotting properties of fibrinogen in plasma","volume":"105","author":"Jensen","year":"2002","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2006.07.005_bib23","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1021\/js950456s","article-title":"Effects of reducing sugars on the chemical stability of human relaxin in the lyophilized state","volume":"85","author":"Li","year":"1996","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.thromres.2006.07.005_bib24","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1248\/cpb.42.5","article-title":"Effect of mannitol crystallinity on the stabilization of enzymes during freeze-drying","volume":"42","author":"Izutsu","year":"1994","journal-title":"Chem Pharm Bull"},{"key":"10.1016\/j.thromres.2006.07.005_bib25","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1023\/A:1018988823116","article-title":"Decreased protein stabilizing effects of cryoprotectants due to crystallization","volume":"42","author":"Izutsu","year":"1993","journal-title":"Pharm Res"},{"key":"10.1016\/j.thromres.2006.07.005_bib26","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1023\/A:1016223101872","article-title":"Glycine crystallization during freezing: the effect of salt form, pH, and ionic strength","volume":"12","author":"Akers","year":"1995","journal-title":"Pharm Res"},{"key":"10.1016\/j.thromres.2006.07.005_bib27","article-title":"Influence of NaCl on excipients used for lyophilization of proteins","author":"Hawe","year":"2003"},{"key":"10.1016\/j.thromres.2006.07.005_bib28","series-title":"Freeze-Drying\/Lyophilization of Pharmaceutical and Biological Products","first-page":"199","article-title":"Regulatory control of freeze-dried products: importance and evaluation of residual moisture","author":"May","year":"1999"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384806002659?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384806002659?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T20:21:18Z","timestamp":1736540478000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384806002659"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S0049384806002659"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2006.07.005","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}